Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AFFIMED-N-V-17937579/news/Affimed-Provides-Data-Update-from-Two-Phase-1-2a-Trials-with-its-Innate-Cell-Engager-AFM24-in-Solid-42228418/?utm_source=whatsapp&utm_medium=social&utm_campaign=share